TransMedics Group Inc (TMDX)
76.04
-3.30
(-4.16%)
USD |
NASDAQ |
Nov 22, 16:00
75.70
-0.34
(-0.45%)
After-Hours: 20:00
TransMedics Group Research and Development Expense (Quarterly): 14.27M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 14.27M |
| June 30, 2024 | 13.86M |
| March 31, 2024 | 11.38M |
| December 31, 2023 | 10.76M |
| September 30, 2023 | 38.34M |
| June 30, 2023 | 8.291M |
| March 31, 2023 | 5.871M |
| December 31, 2022 | 5.756M |
| September 30, 2022 | 6.808M |
| June 30, 2022 | 6.714M |
| March 31, 2022 | 7.534M |
| December 31, 2021 | 6.314M |
| September 30, 2021 | 5.163M |
| June 30, 2021 | 6.295M |
| Date | Value |
|---|---|
| March 31, 2021 | 4.532M |
| December 31, 2020 | 4.548M |
| September 30, 2020 | 4.155M |
| June 30, 2020 | 3.903M |
| March 31, 2020 | 6.225M |
| December 31, 2019 | 6.262M |
| September 30, 2019 | 4.939M |
| June 30, 2019 | 4.787M |
| March 31, 2019 | 3.882M |
| December 31, 2018 | 3.486M |
| September 30, 2018 | 3.272M |
| June 30, 2018 | 3.433M |
| March 31, 2018 | 3.465M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
3.903M
Minimum
Jun 2020
38.34M
Maximum
Sep 2023
8.849M
Average
6.304M
Median
Research and Development Expense (Quarterly) Benchmarks
| Inari Medical Inc | 29.43M |
| Cutera Inc | 4.353M |
| Stereotaxis Inc | 2.454M |
| Electromed Inc | 0.166M |
| Myomo Inc | 1.249M |